Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Endocrinology
Do patients with advanced chronic kidney disease tend to have falsely high HbA1c or falsely low HbA1c levels?
https://doi.org/10.2337/dc22-1399
Related Questions
Does your decision to start or continue Ozempic therapy in patients with diabetic retinopathy depend on the severity of the retinopathy?
What are the treatment options for severe recurrent hypoglycemia in a patient with malignant insulinoma?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?
Do you recommend neuromodulation treatments with an implantable device for patients with chronic painful diabetic neuropathy who have not responded to common oral therapies such as Gabapentin and Amitriptyline?
How do you adjust your management strategy to address the unique needs of anuric end-stage kidney disease patients when treating diabetic ketoacidosis?
Do 5HT4 agonists such as Metoclopramide actually lead to improvement in symptoms for patients with diabetes related gastroparesis?
Would you consider GLP1 R agonist therapy in a patient with a history of severe gallstone pancreatitis that is now post cholecystectomy?
When managing patients with suspected MASLD, what specific criteria or findings would prompt you to refer them to hepatology?
Is there a role for using continuous glucose monitors for perioperative glucose monitoring in patients with diabetes?
